In brief
In a significant ruling, a federal judge has blocked U.S. Health Secretary Robert F. Kennedy Jr. from implementing changes that would reduce the number of recommended vaccines for children. The decision arises from concerns that the alterations could lead to an increase in preventable diseases. The American Academy of Pediatrics and multiple medical groups have voiced their alarm over this issue, leading to a legal challenge against Kennedy's actions, particularly after the dismissal of the previous vaccine advisory committee.
A federal judge on Monday temporarily blocked federal health officials from cutting the number of vaccines recommended for every child, signaling concern that U.S. Health Secretary Robert F. Kennedy Jr. likely violated federal procedures in revamping a key vaccine advisory committee. This decision halts Kennedy’s plan announced in January to end broad recommendations for essential vaccines against diseases like flu, rotavirus, hepatitis A and B, meningitis, and RSV.Leading medical groups, including the American Academy of Pediatrics, raised alarms that changes under Kennedy could undermine vital protections against multiple diseases. They amended a lawsuit they previously filed to challenge Kennedy's decision to halt COVID-19 vaccinations for most children and pregnant women. The ongoing lawsuit, filed in federal court in Boston, reflects growing concern over public health decisions.Kennedy, a prominent figure in the anti-vaccine movement before his appointment, has faced criticism for appointing a new Advisory Committee on Immunization Practices (ACIP) comprised of members with anti-vaccine beliefs. Judge Brian E. Murphy stated that the reconstitution of ACIP might not comply with federal law and has temporarily halted any decisions made by this reformed committee.The Department of Health and Human Services expressed hope for an overturn of the injunction. As ACIP was scheduled to convene to discuss vaccine issues, including COVID-19, its agenda is now in jeopardy, and uncertainty looms over the direction of the nation’s vaccination strategy.
